Evidence map›Paper›PMID 37765389›Full record

ReviewPlants (Basel, Switzerland)2023

Rowanberry-A Source of Bioactive Compounds and Their Biopharmaceutical Properties.

Ofelia Marioara Arvinte, Lăcrimioara Senila, Anca Becze, Sonia Amariei

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Bromatological Profile of Fruits fromAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Inhibitory Effect ofMolecules (Basel, Switzerland) · 2024
    Article
  10. The Antimicrobial Effect ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  11. Fruits of Wild-Grown Shrubs for Health Nutrition.Plant foods for human nutrition (Dordrecht, Netherlands) · 2024
    Review
  12. Exploring FourMolecules (Basel, Switzerland) · 2024
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ofelia Marioara ArvinteFaculty of Food Engineering, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.
Lăcrimioara SenilaINCDO-INOE 2000, Research Institute for Analytical Instrumentation, 67 Donath Street, 400293 Cluj-Napoca, Romania.ORCID 0000-0002-5791-0449
Anca BeczeINCDO-INOE 2000, Research Institute for Analytical Instrumentation, 67 Donath Street, 400293 Cluj-Napoca, Romania.
Sonia AmarieiFaculty of Food Engineering, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After a period of intense development in the synthesis pharmaceutical industry, plants are making a comeback in the public focus as remedies or therapeutic adjuvants and in disease prevention and ensuring the wellbeing and equilibrium of the human body. Plants are being recommended more and more in alimentation, in their natural form, or as extracts, supplements or functional aliments. People, in general, are in search of new sources of nutrients and phytochemicals. As a result, scientific research turns to lesser known and used plants, among them being rowanberries, a species of fruit very rich in nutrients and underused due to their bitter astringent taste and a lack of knowledge regarding the beneficial effects of these fruit. Rowan fruits (rowanberries) are a rich source of vitamins, polysaccharides, organic acids and minerals. They are also a source of natural polyphenols, which are often correlated with the prevention and treatment of modern world diseases. This article presents the existing data regarding the chemical composition, active principles and biopharmaceutical properties of rowan fruits and the different opportunities for their usage.

Indexed as

biopharmaceutical propertiesnutraceutical compoundsphenolic compoundsrowanberry

Identifiers

PMID37765389
PMCPMC10536293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.